Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
8(72.7%)
Phase 3
1(9.1%)
Early Phase 1
1(9.1%)
Phase 1
1(9.1%)
11Total
N/A(8)
Phase 3(1)
Early Phase 1(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)